Risk factors for cutaneous leishmaniasis in a high-altitude forest region of Peru

Risk factors for cutaneous leishmaniasis in a high-altitude forest region of Peru

Abstract Background American cutaneous leishmaniasis (CL) is a neglected tropical disease typically associated with men working in remote, sylvatic environments. We sought to identify CL risk factors in a highly deforested region where anecdotal reports suggested an atypical proportion of women and...

Full description

Bibliographic Details
Main Authors:	Justin T. Lana, Andrés Mallipudi, Ernesto J. Ortiz, Jairo H. Arevalo, Alejandro Llanos-Cuentas, William K. Pan
Format:	Article
Language:	English
Published:	BMC 2021-05-01
Series:	Tropical Medicine and Health
Subjects:	American tegumentary leishmaniasis Agriculture Coffee Case control Deforestation Urbanization
Online Access:	https://doi.org/10.1186/s41182-021-00332-0

Similar Items

Epidemiological profile of leishmaniasis at a reference service in the state of Alagoas, Brazil, from january 2000 to september 2008
by: Willian da Silva Nunes, et al.

Tegumentary leishmaniasis in Northern Argentina: distribution of infection and disease, in three municipalities of Salta, 1990-1992
by: Sosa-Estani Sergio, et al.
Published: (2000-01-01)

Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis
by: Beatriz Coutinho De Oliveira, et al.
Published: (2020-04-01)

New human case reports of cutaneous leishmaniasis by Leishmania (Viannia) naiffi in the Amazon region, Brazil
by: Luanda de Paula FIGUEIRA, et al.
Published: (2017-03-01)

Otorhinolaryngologic manifestations relating American Tegumentary Leishmaniasis: literature review
by: Palheta Neto, Francisco Xavier, et al.
Published: (2008-12-01)

Treatment of American tegumentary leishmaniasis in special populations: a summary of evidence
by: Juliana Saboia Fontenele e Silva, et al.
Published: (2013-12-01)

Dogs Harbor <i>Leishmania braziliensis</i> and Participate in the Transmission Cycle of Human Tegumentary Leishmaniasis
by: Jamile Lago, et al.
Published: (2023-07-01)

Geographic Clustering of Leishmaniasis in Northeastern Brazil
by: Albert Schriefer, et al.
Published: (2009-06-01)

Opinion Article: NK Cells in Cutaneous Leishmaniasis: Protection or Damage?
by: Marton Kaique de Andrade Cavalcante, et al.
Published: (2022-07-01)

Overcoming the Negligence in Laboratory Diagnosis of Mucosal Leishmaniasis
by: Lilian Motta Cantanhêde, et al.
Published: (2021-09-01)

Polymerase chain reaction with lesion scrapping for the diagnosis of human American tegumentary leishmaniasis
by: Eneide Aparecida Sabaini Venazzi, et al.
Published: (2006-06-01)

Immunophenotypic characterization of patients with American cutaneous leishmaniasis prior to and after treatment in Pernambuco, Brazil
by: AF Almeida, et al.
Published: (2011-01-01)

Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)
by: Lucia Regina Brahim, et al.

Clinical and laboratory profiles of patients with early spontaneous healing in cutaneous localized leishmaniasis: a historical cohort study
by: Carla Oliveira-Ribeiro, et al.
Published: (2017-08-01)

Identification of Immunodominant Antigens From a First-Generation Vaccine Against Cutaneous Leishmaniasis
by: María José Germanó, et al.
Published: (2022-05-01)

IFN-γ Response Is Associated to Time Exposure Among Asymptomatic Immune Responders That Visited American Tegumentary Leishmaniasis Endemic Areas in Peru
by: Ivan Best, et al.
Published: (2018-08-01)

COVID-19 Pandemic Causes Increased Clinic Visits with Diagnosis of Tegumentary Leishmaniasis in Brazil in 2020
by: Marileia Chaves Andrade, et al.
Published: (2021-12-01)

Place of Serology in the Diagnosis of Zoonotic Leishmaniases With a Focus on Visceral Leishmaniasis Due to Leishmania infantum
by: Maude F. Lévêque, et al.
Published: (2020-02-01)

Domestic and peridomestic transmission of American cutaneous leishmaniasis: changing epidemiological patterns present new control opportunities
by: Diarmid Campbell-Lendrum, et al.
Published: (2001-02-01)

Protective and pathologic immune responses in human tegumentary leishmaniasis
by: Edgar M Carvalho, et al.
Published: (2012-10-01)

Leishmanial antigens in the diagnosis of active lesions and ancient scars of American tegumentary leishmaniasis patients
by: Armando Schubach, et al.
Published: (2001-10-01)

Editorial: Cutaneous Leishmaniasis: Exploring Pathogenesis and Immunomodulatory Approaches
by: Wander Rogério Pavanelli, et al.
Published: (2022-01-01)

Traditional treatments in an endemic area of cutaneous leishmaniasis in Peru
by: Roberto Pineda-Reyes, et al.
Published: (2015-12-01)

Imunização específica nas leishmanioses tegumentares: revisão Specific immunization in tegumentary leishmaniasis (A review)
by: M. Barral Netto, et al.
Published: (1987-06-01)

Cutaneous and visceral leishmaniasis co-infection in dogs from Rio de Janeiro, Brazil: evaluation by specific PCR and RFLP-PCR assays
by: Marize Quinhones Pires, et al.
Published: (2014-04-01)

Tumor necrosis factor-α in human American tegumentary leishmaniasis
by: Alda Maria Da-Cruz, et al.
Published: (1996-04-01)

Persistent Infections by Leishmania (Viannia) braziliensis
by: José Luis Ramírez, et al.
Published: (1997-05-01)

In vitro and in vivo Anti-leishmanial Potential of [Ag (PTA) 4 ]BF 4 and [Ag(HBPz 3 )(PPh 3 )] Silver Complexes
by: Pauline de Faria Soldera, et al.
Published: (2022-04-01)

First report of Leishmania (Viannia) lindenbergi causing tegumentary leishmaniasis in the Brazilian western Amazon region
by: Cantanhêde Lilian Motta, et al.
Published: (2019-01-01)

Virulence factor RNA transcript expression in the Leishmania Viannia subgenus: influence of species, isolate source, and Leishmania RNA virus-1
by: Ruwandi Kariyawasam, et al.
Published: (2019-04-01)

The Binomial Parasite-Host Immunity in the Healing Process and in Reactivation of Human Tegumentary Leishmaniasis
by: Fatima Conceição-Silva, et al.
Published: (2018-06-01)

Comparison between Colorimetric In Situ Hybridization, Histopathology, and Immunohistochemistry for the Diagnosis of New World Cutaneous Leishmaniasis in Human Skin Samples
by: Luiz Cláudio Ferreira, et al.
Published: (2022-11-01)

Force of infection and evolution of lesions of canine tegumentary leishmaniasis in Northwestern Argentina
by: Jorge Diego Marco, et al.
Published: (2001-07-01)

Multiparametric analysis of host and parasite elements in new world tegumentary leishmaniasis
by: Bruna Caroline de Carvalho, et al.
Published: (2022-08-01)

Severity of tegumentary leishmaniasis is not exclusively associated with Leishmania RNA virus 1 infection in Brazil
by: Luiza de Oliveira Ramos Pereira, et al.
Published: (2013-08-01)

Previous History of American Tegumentary Leishmaniasis Alters Susceptibility and Immune Response Against Schistosoma mansoni Infection in Humans
by: Guilherme Silva Miranda, et al.
Published: (2021-03-01)

Identification and purification of immunogenic proteins from nonliving promastigote polyvalent Leishmania vaccine (Leishvacin®)
by: Sandra Regina Afonso Cardoso, et al.
Published: (2003-04-01)

Medida do volume da úlcera cutânea na leishmaniosetegumentar
by: Dalmo Correia, et al.
Published: (1996-12-01)

Peptide Vaccines for Leishmaniasis
by: Rory C. F. De Brito, et al.
Published: (2018-05-01)

Procedência de pacientes portadores de leishmaniose tegumentar americana nas áreas endêmicas de Três Braços e Corte de Pedra - Estado da Bahia - Brasil
by: Jackson M. L. Costa, et al.
Published: (1988-09-01)